Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertram Pitt

Showing results (561-570 of 688) with videos related to

Pageof 69
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and AdiposityCheng-Hsuan Tsai, Justin M Chan, Julia Milks, et al.
Journal of the American Heart Association|October 9, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Journal of Cardiac Failure|March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary StudyAnis Ismail, Grace Erne, Alexi Vasbinder, et al.
Circulation|May 22, 2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialStephen J Greene, Eric J Velazquez, Kevin J Anstrom, et al.
Circulation. Heart Failure|May 19, 2023
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF TrialsMichael E Nassif, Sheryl L Windsor, Kensey Gosch, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
European Heart Journal|May 28, 2026
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysisRyohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology|March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal FunctionIris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
American Heart Journal|June 27, 2024
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarctionMarc-André d'Entremont, Shun Fu Lee, Rajibul Mian, et al.
European Journal of Heart Failure|May 14, 2024
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trialMuthiah Vaduganathan, Brian L Claggett, Carolyn S P Lam, et al.
Pageof 69

Showing results (561-570 of 688) with videos related to

Sort By:
Pageof 69
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and AdiposityCheng-Hsuan Tsai, Justin M Chan, Julia Milks, et al.
Journal of the American Heart Association|October 9, 2025
Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic ArrestSina Danesh, Fazal Khan, Trevor Chopko, et al.
Journal of Cardiac Failure|March 2, 2026
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients with Diabetes and Heart Failure: A SOLOIST-WHF Ancillary StudyAnis Ismail, Grace Erne, Alexi Vasbinder, et al.
Circulation|May 22, 2023
Effect of Torsemide Versus Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical TrialStephen J Greene, Eric J Velazquez, Kevin J Anstrom, et al.
Circulation. Heart Failure|May 19, 2023
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF TrialsMichael E Nassif, Sheryl L Windsor, Kensey Gosch, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 15, 2014
Predictors of contemporary coronary artery bypass grafting outcomesRichard D Weisel, Nancy Nussmeier, Mark F Newman, et al.
European Heart Journal|May 28, 2026
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysisRyohei Ono, Misato Chimura, Kieran F Docherty, et al.
Journal of the American College of Cardiology|March 5, 2021
Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal FunctionIris E Beldhuis, Peder L Myhre, Michael Bristow, et al.
American Heart Journal|June 27, 2024
Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: A 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarctionMarc-André d'Entremont, Shun Fu Lee, Rajibul Mian, et al.
European Journal of Heart Failure|May 14, 2024
Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS-HF trialMuthiah Vaduganathan, Brian L Claggett, Carolyn S P Lam, et al.
Pageof 69